Steven C. Crouse - 02 Jun 2026 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship: President - Diag & Spatial Bi
Issuer ticker: TECH
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:28:40 UTC
Prior SEC filing: 05 May 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney previously filed.

Key filing fact

Steven C. Crouse filed Form 4 for BIO-TECHNE Corp (TECH) on 04 Jun 2026.

Key facts

This page summarizes Steven C. Crouse's Form 4 filing for BIO-TECHNE Corp (TECH).
3 reported transactions and 16 derivative rows are listed below.
Accepted by SEC: 04 Jun 2026, 16:28.

Change

Previous filing in this sequence was filed on 05 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002065241 Primary reporting owner

Crouse Steven C.

Relationship: President - Diag & Spatial Bi
Address: 614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature: /s/ Andrew Nick as Attorney-in-Fact for Steven C. Crouse pursuant to Power of Attorney previously filed.
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
Shares: +600
Change %: +9.4%
Price
Shares after: 6,977
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F17

TECH transaction

Common Stock

Tax liability

Transaction value
Shares: -216
Change %: -3.1%
Price: $49.77^*
Shares after: 6,761
Date: 02 Jun 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -600
Change %: -33%
Price: $0.000000^*
Shares after: 1,200
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 600
Exercise price
Footnotes: F1, F3

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 794
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 794
Exercise price
Footnotes: F1, F2

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,379
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,379
Exercise price
Footnotes: F1, F4

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,737
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,737
Exercise price
Footnotes: F1, F5

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,529
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,529
Exercise price
Footnotes: F1, F6

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,856
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,856
Exercise price: $97.13
Footnotes: F7

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,032
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,032
Exercise price: $120.46
Footnotes: F7

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 24,560
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,560
Exercise price: $94.52
Footnotes: F8

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,649
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,649
Exercise price: $84.61
Footnotes: F9

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 7,327
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,327
Exercise price: $73.46
Footnotes: F10

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,133
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,133
Exercise price: $74.91
Footnotes: F11

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,434
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,434
Exercise price: $48.61
Footnotes: F12

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,151
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,151
Exercise price: $53.60
Footnotes: F13

TECH holding Derivative

Performance Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,387
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,387
Exercise price
Footnotes: F1, F14

TECH holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 735
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 735
Exercise price
Footnotes: F1, F15

TECH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,911
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,911
Exercise price: $57.82
Footnotes: F16

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 17 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

Footnote F2

794 restricted stock units vest on 5/1/2027.

Footnote F3

600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028.

Footnote F4

1,379 restricted stock units vest on 8/15/2026.

Footnote F5

1,868 restricted stock units vest on 8/15/2026 and 1,869 restricted stock units vest on 8/15/2027.

Footnote F6

2,176 restricted stock units vest on each of 8/15/2026 and 8/15/2028; and 2,177 restricted stock units vest on 8/15/2027.

Footnote F7

100% vested.

Footnote F8

Options to purchase 6,140 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.

Footnote F9

Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.

Footnote F10

Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.

Footnote F11

Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.

Footnote F12

Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.

Footnote F13

Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.

Footnote F14

Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Footnote F15

245 restricted stock units vest on 3/2/2027, 3/2/2028 and 3/2/2029.

Footnote F16

Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.

Footnote F17

Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .